Key facts
- This page summarizes Calli Bucci's Form 5/A - Amendment filing for PARALLAX HEALTH SCIENCES, INC..
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 29 Mar 2022, 13:54.
Calli Bucci - 31 Dec 2021 Form 5/A - Amendment Insider Report for PARALLAX HEALTH SCIENCES, INC.
- Reporting relationship
- CFO, Secretary, Treasurer, Director
- Issuer ticker
- N/A
- Reported as of
- 31 Dec 2021
- Net transaction value
- -$3,750
- SEC form
- 5/A - Amendment
- Accepted by SEC
- 29 Mar 2022, 13:54:25 UTC
- Original report date
- 04 Mar 2022
- Prior SEC filing
- 16 Jun 2021
- Source filing
- View source filing
- Reporting owner signature
- CALLI BUCCI
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Calli Bucci filed Form 5/A - Amendment for PARALLAX HEALTH SCIENCES, INC. on 29 Mar 2022.
Change
- Previous filing in this sequence was filed on 16 Jun 2021.
- Current net transaction value: -$3,750.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 5/A - Amendment disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PRLX
transaction
Derivative
WARRANTS
Disposed to Issuer
- Transaction value
- $3,750
- Shares
- -15,000
- Change %
- -1.4%
- Price
- $0.2500
- Shares after
- 1,030,000
- Date
- 30 Sep 2021
- Ownership
- Direct
- Underlying class
- COMMON STOCK
- Underlying amount
- 625,000
- Exercise price
- $0.2500
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Warrants originally granted on 09/30/2018 in connection with Series C Preferred Shares expired 09/30/2021.